FLT3 and acute myeloid leukemia: Thus, in a recent study carried out on a cohort of 481 AML patients the impact of FLT3 mutations on core binding factor (CBF)-AMLs, normal-karyotype (NK) AMLs, and poor-risk AMLs was evaluated [72].